The management of smoldering multiple myeloma (MM) is undergoing a significant transformation, driven by growing evidence that early intervention can meaningfully delay progression to active disease.

Published in JAMA Network Open, the study found that women with breast cancer living in Medicaid expansion states had a 4.8% lower risk of death compared with those in nonexpansion states. Researchers ...

Bidisha Mandal, PhD, a professor at Washington State University, continued the conversation about her study, “Telehealth for Primary and Preventive Care Among Food-Insecure Individuals,” recently ...

Glaucoma medication adherence and glaucoma-related distress were both improved when patients used the Support, Educate, Empower (SEE) glaucoma coaching program vs the standard written education ...

The federal IACC, created in 2006, provides nonbinding guidance that helps align national autism research and services and supports coordination of approximately $2 billion in annual government ...

From innovative therapies to global care strategies, HIV experts at CROI 2026 share the breakthroughs and lessons they hope every viewer, near or far, takes home.

From innovative therapies to global care strategies, HIV experts at CROI 2026 share the breakthroughs and lessons they hope ...

Experts explain stage IV lung cancer goals, PD‑L1-driven therapy choices, and when to intensify with chemo plus dual ...

Wildfire smoke from the Canadian wildfires in 2023 was linked to a higher incidence of severe strokes and increased hemorrhagic risk, according to new study findings.

New CRC diagnoses increasingly occur before age 65, with incidence rising 3% annually in ages 20–49 and 45% of cases now occurring under 65 years. Distal colon and rectal tumors drive early-onset ...

The gap in shared decision-making was similarly notable. Clinicians rated their own effectiveness in involving patients at 80.8 out of 100, while patients rated clinician involvement at only 69.1.

Povorcitinib 75 mg achieved high-threshold lesion clearance by week 12, including 100% draining-tunnel reduction in 12%–57% and total abscess clearance in 22%–62% of participants. Phase 3 data show ...